Balance Sheet for Taro Pharmaceutical Industries Ltd. (TARO)

$ 76.14   0.22 (+0.29%) Volume: 36.34k 6:30 PM EST Nov 12, 2019
After Hours:  $ 76.14 0.00 (0.00%) Volume: 75 4:02 PM EST Nov 12, 2019
Statement: View:
Assets [+] in Millions of Dollars
03/2019 03/2018 03/2017 03/2016 03/2015
Cash and Equivalents 567 577 600 577 482
Restrictable Cash - - - - 0
Marketable Securities 482 846 786 652 438
Accounts Receivable 238 206 204 239 222
Loans Receivable - - - - -
Other Receivables 29 104 114 42 2
Receivables 277 322 326 284 263
Inventories, Raw Materials 45 56 53 48 43
Inventories, Work in Progress 33 27 27 27 27
Inventories, Purchased Components - - - - -
Inventories, Finished Goods 66 57 57 60 47
Inventories, Other 153 149 145 142 123
Inventories, Adjustments & Allowances - - - - -
Inventories 148 145 141 139 120
Prepaid Expenses 8 8 12 13 11
Current Deferred Income Taxes - - 132 212 200
Other Current Assets - - - - -
Total Current Assets 1,483 1,897 1,999 1,878 1,514
Land and Improvements 8 8 8 8 8
Buildings and Improvement 186 174 161 153 150
Machinery, Furniture and Equipment 249 246 230 216 212
Construction in Progress - - - - -
Fixed Assets, Other - - - - -
Fixed Assets, Total 443 428 398 377 370
Gross Fixed Assets 443 428 398 377 370
Accumulated Depreciation (236) (234) (218) (217) (217)
Net Fixed Assets 206 194 180 159 153
Intangibles 9 7 6 8 13
Cost in Excess 7 7 7 7 7
Non-Current Deferred Income Taxes 111 87 10 4 4
Other Non-Current Assets 2 2 3 2 2
Total Non-Current Assets 653 537 291 310 224
Total Assets 2,135 2,433 2,290 2,188 1,738
Liabilities [+] in Millions of Dollars
03/2019 03/2018 03/2017 03/2016 03/2015
Accounts Payable 37 30 23 31 32
Short Term Debt - - - 2 1
Notes Payable - - - - -
Accrued Expenses 37 37 33 36 35
Accrued Liabilities 37 37 33 36 35
Deferred Revenues 9 0 0 1 0
Current Deferred Income Taxes 12 56 74 (12) (70)
Other Current Liabilities 133 148 153 175 242
Total Current Liabilities 217 216 210 245 310
Long Term Debt - - - 9 5
Deferred Income Tax 3 3 2 2 2
Other Non-Current Liabilities 4 4 4 (6) 3
Minority Interest 6 5 6 6 6
Capital Lease Obligations - - - - -
Preferred Securities of Subsidiary Trust - - - - -
Preferred Equity Outside Shareholders' Equity - - - - -
Total Non-Current Liabilities 13 12 12 11 16
Total Liabilities 230 228 222 257 326
Preferred Shareholder's Equity - - - - -
Common Shareholder's Equity 1,906 2,205 2,067 1,931 1,412
Common Par 1 1 1 1 1
Additional Paid in Capital 262 262 262 262 262
Cumulative Translation Adjustments - - - - -
Retained Earnings 2,481 2,662 2,451 1,995 1,454
Treasury Stock 695 610 499 204 194
Other Equity Adjustments (144) (110) (148) (123) (111)
Total Capitalization 1,906 2,205 2,067 1,940 1,417
Total Equity 1,906 2,205 2,067 1,931 1,412
Total Liabilities & Shareholder's Equity 2,135 2,433 2,290 2,188 1,738
Cash Flow 282 210 457 541 485
Working Capital 1,266 1,681 1,789 1,632 1,204
Free Cash Flow 293 294 402 376 387
Invested Capital 1,906 2,205 2,067 1,931 1,417
Shares Outstanding - Common Class Only 39 39 41 43 43
Preferred Shares Outstanding - - - - -
Total Ordinary Shares 39 39 41 43 43
Total Common Shares Outstanding 39 39 41 43 43
Treasury Shares 7 6 5 2 2
Basic Weighted Shares Outstanding 39 40 41 43 43
Diluted Weighted Shares Outstanding 39 40 41 43 43